Copy

Sponsored by    

 

Boston, Briefly

He experienced a severe reaction to Moderna’s Covid-19 vaccine candidate. He’s still a believer

By Matthew Herper

Courtesy Ian Haydon

Clinical trials patients are usually faceless. With Modern's Covid-19 vaccine candidate, it has a much more visible advocate: trial volunteer Ian Haydon.

Read More

Hospital records hold valuable Covid-19 data. Making it usable is time-consuming work

By Rebecca Robbins

ALEX EDELMAN/AFP via Getty Images

Data from hospital records will be critical to getting a better handle on Covid-19, but making that data usable for researchers is a painstaking process.

Read More

Moderna executives have cashed out $89M in shares this year, as stock price has soared on vaccine hopes

By Damian Garde

Ruby Wallau for STAT

With the firm in the spotlight for its Covid-19 vaccine, five executives have initiated nearly three times as many stock transactions than in all of 2019.

Read More

Wastewater testing gains traction as a Covid-19 early warning system

By Sharon Begley

Justin Sullivan/Getty Images

What a month ago had been merely an intriguing lab finding about testing wastewater to detect the coronavirus has leapt to the threshold of real-world use.

Read More

STAT Plus: Vertex angers U.K. cystic fibrosis patients with a delay in submitting data for its newest therapy

By Ed Silverman

Bill Sikes/AP

Vertex has sparked anger among cystic fibrosis patients by requesting extra time to submit evidence for a new therapy to a U.K. cost-effectiveness agency

Read More

STAT Plus: Startup Spotlight: Going after immune regulators when they cause disease instead of prevent it

By Elizabeth Cooney

Alex Hogan/STAT

Q32 Bio has two targets in its sights: the two arms of the immune system.

Read More

STAT Plus: ‘One thing cancer patients don’t generally have is time’: New cancer research leader brings urgency to Sanofi

By Elizabeth Cooney

Kristoffer Tripplaar/Sipa via AP Images

Peter Adamson, a pediatric oncologist, brings urgency to his new role as Sanofi's research leader in cancer and pediatric innovation.

Read More

Thursday, May 28, 2020

STAT

Facebook   Twitter   YouTube   Instagram

1 Exchange Pl, Suite 201, Boston, MA 02109
©2020, All Rights Reserved.
I no longer wish to receive STAT emails
Update Email Preferences | Contact Us
5cP.gif?contact_status=<<Contact Status>>